Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Type I Diabetes I: Introduction

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

Insulin Formulations: Types and Delivery

Insulin Formulations: Types and Delivery

Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into rapid-acting...

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Self-Regulation Mediates the Relationship Between Stress and Quality of Life in Shift-Working Healthcare Professionals: Behavioral Clustering Insights.

European journal of investigation in health, psychology and education·2025

Same author

Exploring RNA-Seq Data Analysis Through Visualization Techniques and Tools: A Systematic Review of Opportunities and Limitations for Clinical Applications.

Bioengineering (Basel, Switzerland)·2025

Same author

Data Preprocessing Techniques for AI and Machine Learning Readiness: Scoping Review of Wearable Sensor Data in Cancer Care.

JMIR mHealth and uHealth·2024

Same author

Post-transplant dynamic risk prediction.

Nature computational science·2024

Same author

A Case Study of Enhancing the Data Science Capacity of an RCMI Program at a Historically Black Medical College.

International journal of environmental research and public health·2023

Same author

Electronic Health Record Portal Use by Family Caregivers of Patients Undergoing Hematopoietic Cell Transplantation: United States National Survey Study.

JMIR cancer·2021

Search research articles

Related Experiment Video

Updated: Jun 5, 2026

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Personalized Type 1 Diabetes Management: Reinforcement Learning-Based Insulin Dosing and Glucose Forecasting.

Ernest M Taku¹, Vibhuti Gupta², Ashutosh Singhal¹

¹Department of Biomedical Data Science, School of Applied Computational Sciences, Meharry Medical College, Nashville, TN, United States.

|June 3, 2026

Summary

This study developed a deep Q-network reinforcement learning system for personalized insulin dosing in type 1 diabetes. The model effectively adapted insulin recommendations using real-time data, improving glucose control and minimizing hypo- and hyperglycemia risks.

Keywords:

adaptive insulin regimens artificial intelligence deep Q-network health care machine learning personalized insulin dosing reinforcement learning

Related Experiment Videos

Last Updated: Jun 5, 2026

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Area of Science:

Artificial Intelligence
Biomedical Engineering
Endocrinology

Background:

Type 1 diabetes management is complex due to glucose metabolism variability.
Traditional insulin regimens struggle with individual fluctuations in diet, activity, and stress.
Reinforcement learning (RL) offers adaptive, real-time insulin adjustments for better glycemic control.

Purpose of the Study:

Develop a deep Q-network (DQN)-based RL system for dynamic insulin dosing.
Personalize insulin recommendations using continuous glucose monitoring, meal, and activity data.
Enhance glucose control and patient safety by adapting to physiological changes.

Main Methods:

Utilized the OhioT1DM dataset (continuous glucose, insulin, activity data).
Designed an RL agent with a 2-hour state window (glucose, insulin, lifestyle factors).
Employed a reward function favoring target glucose range (70-180 mg/dL) and penalizing deviations.

Main Results:

Achieved a mean glucose level of 80.06 mg/dL with a reward score of 10.
Demonstrated effective glucose regulation with 64.06% time in target range.
Reported RMSE of 12.39 mg/dL and MAE of 9.85 mg/dL, indicating stable predictions.

Conclusions:

The DQN-based RL model effectively personalizes insulin dosing, reducing hypo- and hyperglycemia risks.
This adaptive approach significantly advances traditional diabetes management strategies.
The system offers a scalable solution with potential for enhanced clinical trust and transparency.